ANNEXON, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
ANNEXON, INC. (ANNX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $500.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-12
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $400.00K, a 300.00% increase year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $100.00K, a 0.00% change year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $400.00K, a 42.86% decline year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $500.00K, a 58.33% decline from fiscal 2024.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $1.20M, a 300.00% increase from fiscal 2023.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $300.00K, a 2508.70% increase from fiscal 2022.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $11.50K, a 99.82% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $500.00K 10-Q · filed 2026-08-12 | $900.00K derived: sum of 3 quarters · filed 2026-08-12 | $900.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-07 | $500.00K derived: sum of 2 quarters · filed 2026-05-07 | $500.00K derived: sum of 3 quarters · filed 2026-05-07 | $600.00K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $400.00K derived: sum of 2 quarters · filed 2026-03-30 | $500.00K derived: sum of 3 quarters · filed 2026-03-30 | $500.00K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 | $100.00K derived: sum of 2 quarters · filed 2025-11-10 | $100.00K 10-Q · filed 2025-11-10 | $900.00K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-06-30 | $100.00K 10-Q · filed 2025-08-14 | $100.00K 10-Q · filed 2026-08-12 | $900.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.10M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-03-31 | $100.00K 10-Q · filed 2026-05-07 | $800.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.00M derived: sum of 3 quarters · filed 2026-05-07 | $1.10M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $900.00K derived: sum of 2 quarters · filed 2026-03-30 | $1.00M derived: sum of 3 quarters · filed 2026-03-30 | $1.20M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-10 | $300.00K derived: sum of 2 quarters · filed 2025-11-10 | $500.00K 10-Q · filed 2025-11-10 | $600.00K derived: sum of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-14 | $400.00K 10-Q · filed 2025-08-14 | $400.00K derived: sum of 3 quarters · filed 2025-08-14 | $400.00K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $300.00K 10-Q · filed 2025-05-12 | $300.00K derived: sum of 2 quarters · filed 2025-05-12 | $300.00K derived: sum of 3 quarters · filed 2025-05-12 | $300.00K derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $0.00 derived: sum of 3 quarters · filed 2025-03-03 | $300.00K 10-K · filed 2025-03-03 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $300.00K 10-Q · filed 2024-11-14 | $306.50K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-12 | $300.00K 10-Q · filed 2024-08-12 | $306.50K derived: sum of 3 quarters · filed 2024-08-12 | $309.00K derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | $300.00K 10-Q · filed 2024-05-13 | $306.50K derived: sum of 2 quarters · filed 2024-05-13 | $309.00K derived: sum of 3 quarters · filed 2024-05-13 | $309.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $6.50K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $9.00K derived: sum of 2 quarters · filed 2024-03-26 | $9.00K derived: sum of 3 quarters · filed 2024-03-26 | $11.50K 10-K · filed 2024-03-26 | |
| 2022-09-30 | $2.50K 10-Q · filed 2022-11-03 | $2.50K derived: sum of 2 quarters · filed 2023-08-07 | $5.00K 10-Q · filed 2023-11-13 | $2.50M derived: sum of 4 quarters · filed 2023-08-07 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-07 | $2.50K 10-Q · filed 2023-08-07 | $2.50M derived: sum of 3 quarters · filed 2023-08-07 | $3.20M derived: sum of 4 quarters · filed 2023-08-07 | |
| 2022-03-31 | $2.50K 10-Q · filed 2023-05-08 | $2.50M derived: sum of 2 quarters · filed 2023-05-08 | $3.20M derived: sum of 3 quarters · filed 2023-05-08 | $5.40M derived: sum of 4 quarters · filed 2023-05-08 | |
| 2021-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $3.20M derived: sum of 2 quarters · filed 2023-03-06 | $5.40M derived: sum of 3 quarters · filed 2023-03-06 | $6.40M 10-K · filed 2023-03-06 | |
| 2021-09-30 | $700.00K 10-Q · filed 2022-11-03 | $2.90M derived: sum of 2 quarters · filed 2022-11-03 | $3.90M 10-Q · filed 2022-11-03 | $4.00M derived: sum of 4 quarters · filed 2022-11-03 | |
| 2021-06-30 | $2.20M 10-Q · filed 2022-08-08 | $3.30M 10-Q · filed 2022-08-08 | $3.30M derived: sum of 3 quarters · filed 2022-08-08 | $3.50M derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-03-31 | $1.10M 10-Q · filed 2022-05-09 | $1.10M derived: sum of 2 quarters · filed 2022-05-09 | $1.30M derived: sum of 3 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $200.00K derived: sum of 2 quarters · filed 2022-03-01 | $200.00K 10-K · filed 2022-03-01 | $181.00K 10-K · filed 2021-03-25 | |
| 2020-09-30 | $200.00K 10-Q · filed 2021-11-09 | $200.00K 10-Q · filed 2021-11-09 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $8.00K derived: sum of 3 quarters · filed 2021-03-25 | $8.00K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-16 | $8.00K derived: sum of 2 quarters · filed 2020-11-16 | $8.00K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $8.00K 10-Q · filed 2020-09-08 | $8.00K 10-Q · filed 2020-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |